168 related articles for article (PubMed ID: 10233893)
1. Agonist-induced regulation of myosin phosphatase activity in human platelets through activation of Rho-kinase.
Suzuki Y; Yamamoto M; Wada H; Ito M; Nakano T; Sasaki Y; Narumiya S; Shiku H; Nishikawa M
Blood; 1999 May; 93(10):3408-17. PubMed ID: 10233893
[TBL] [Abstract][Full Text] [Related]
2. Protein kinase C-catalyzed phosphorylation of an inhibitory phosphoprotein of myosin phosphatase is involved in human platelet secretion.
Watanabe Y; Ito M; Kataoka Y; Wada H; Koyama M; Feng J; Shiku H; Nishikawa M
Blood; 2001 Jun; 97(12):3798-805. PubMed ID: 11389019
[TBL] [Abstract][Full Text] [Related]
3. Rho kinase inhibitor HA-1077 prevents Rho-mediated myosin phosphatase inhibition in smooth muscle cells.
Nagumo H; Sasaki Y; Ono Y; Okamoto H; Seto M; Takuwa Y
Am J Physiol Cell Physiol; 2000 Jan; 278(1):C57-65. PubMed ID: 10644512
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Rho-associated kinase blocks agonist-induced Ca2+ sensitization of myosin phosphorylation and force in guinea-pig ileum.
Swärd K; Dreja K; Susnjar M; Hellstrand P; Hartshorne DJ; Walsh MP
J Physiol; 2000 Jan; 522 Pt 1(Pt 1):33-49. PubMed ID: 10618150
[TBL] [Abstract][Full Text] [Related]
5. Involvement of Rho-kinase-mediated phosphorylation of myosin light chain in enhancement of cerebral vasospasm.
Sato M; Tani E; Fujikawa H; Kaibuchi K
Circ Res; 2000 Aug; 87(3):195-200. PubMed ID: 10926869
[TBL] [Abstract][Full Text] [Related]
6. Platelet shape change is mediated by both calcium-dependent and -independent signaling pathways. Role of p160 Rho-associated coiled-coil-containing protein kinase in platelet shape change.
Paul BZ; Daniel JL; Kunapuli SP
J Biol Chem; 1999 Oct; 274(40):28293-300. PubMed ID: 10497186
[TBL] [Abstract][Full Text] [Related]
7. Regulation of myosin phosphatase through phosphorylation of the myosin-binding subunit in platelet activation.
Nakai K; Suzuki Y; Kihira H; Wada H; Fujioka M; Ito M; Nakano T; Kaibuchi K; Shiku H; Nishikawa M
Blood; 1997 Nov; 90(10):3936-42. PubMed ID: 9354661
[TBL] [Abstract][Full Text] [Related]
8. cGMP signaling inhibits platelet shape change through regulation of the RhoA-Rho Kinase-MLC phosphatase signaling pathway.
Aburima A; Walladbegi K; Wake JD; Naseem KM
J Thromb Haemost; 2017 Aug; 15(8):1668-1678. PubMed ID: 28509344
[TBL] [Abstract][Full Text] [Related]
9. Inhibition by Rho-kinase and protein kinase C of myosin phosphatase is involved in thrombin-induced shape change of megakaryocytic leukemia cell line UT-7/TPO.
Yazaki A; Tamaru S; Sasaki Y; Komatsu N; Wada H; Shiku H; Nishikawa M
Cell Signal; 2005 Mar; 17(3):321-30. PubMed ID: 15567063
[TBL] [Abstract][Full Text] [Related]
10. Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase).
Kimura K; Ito M; Amano M; Chihara K; Fukata Y; Nakafuku M; Yamamori B; Feng J; Nakano T; Okawa K; Iwamatsu A; Kaibuchi K
Science; 1996 Jul; 273(5272):245-8. PubMed ID: 8662509
[TBL] [Abstract][Full Text] [Related]
11. cAMP signaling regulates platelet myosin light chain (MLC) phosphorylation and shape change through targeting the RhoA-Rho kinase-MLC phosphatase signaling pathway.
Aburima A; Wraith KS; Raslan Z; Law R; Magwenzi S; Naseem KM
Blood; 2013 Nov; 122(20):3533-45. PubMed ID: 24100445
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of myosin-binding subunit (MBS) of myosin phosphatase by Rho-kinase in vivo.
Kawano Y; Fukata Y; Oshiro N; Amano M; Nakamura T; Ito M; Matsumura F; Inagaki M; Kaibuchi K
J Cell Biol; 1999 Nov; 147(5):1023-38. PubMed ID: 10579722
[TBL] [Abstract][Full Text] [Related]
13. Thrombin-induced activation of RhoA in platelet shape change.
Bodie SL; Ford I; Greaves M; Nixon GF
Biochem Biophys Res Commun; 2001 Sep; 287(1):71-6. PubMed ID: 11549255
[TBL] [Abstract][Full Text] [Related]
14. Essential role of rho kinase in the Ca2+ sensitization of prostaglandin F(2alpha)-induced contraction of rabbit aortae.
Ito K; Shimomura E; Iwanaga T; Shiraishi M; Shindo K; Nakamura J; Nagumo H; Seto M; Sasaki Y; Takuwa Y
J Physiol; 2003 Feb; 546(Pt 3):823-36. PubMed ID: 12563007
[TBL] [Abstract][Full Text] [Related]
15. Agonists trigger G protein-mediated activation of the CPI-17 inhibitor phosphoprotein of myosin light chain phosphatase to enhance vascular smooth muscle contractility.
Kitazawa T; Eto M; Woodsome TP; Brautigan DL
J Biol Chem; 2000 Apr; 275(14):9897-900. PubMed ID: 10744661
[TBL] [Abstract][Full Text] [Related]
16. A major role for the rho-associated coiled coil forming protein kinase in G-protein-mediated Ca2+ sensitization through inhibition of myosin phosphatase in rabbit trachea.
Iizuka K; Yoshii A; Samizo K; Tsukagoshi H; Ishizuka T; Dobashi K; Nakazawa T; Mori M
Br J Pharmacol; 1999 Oct; 128(4):925-33. PubMed ID: 10556927
[TBL] [Abstract][Full Text] [Related]
17. Myotonic dystrophy protein kinase phosphorylates the myosin phosphatase targeting subunit and inhibits myosin phosphatase activity.
Murányi A; Zhang R; Liu F; Hirano K; Ito M; Epstein HF; Hartshorne DJ
FEBS Lett; 2001 Mar; 493(2-3):80-4. PubMed ID: 11287000
[TBL] [Abstract][Full Text] [Related]
18. Thiophosphorylation-induced Ca(2+) sensitization of guinea-pig ileum contractility is not mediated by Rho-associated kinase.
Pfitzer G; Sonntag-Bensch D; Brkic-Koric D
J Physiol; 2001 Jun; 533(Pt 3):651-64. PubMed ID: 11410624
[TBL] [Abstract][Full Text] [Related]
19. Ca2+-dependent activation of Rho and Rho kinase in membrane depolarization-induced and receptor stimulation-induced vascular smooth muscle contraction.
Sakurada S; Takuwa N; Sugimoto N; Wang Y; Seto M; Sasaki Y; Takuwa Y
Circ Res; 2003 Sep; 93(6):548-56. PubMed ID: 12919947
[TBL] [Abstract][Full Text] [Related]
20. Regulation of myosin-bound protein phosphatase by insulin in vascular smooth muscle cells: evaluation of the role of Rho kinase and phosphatidylinositol-3-kinase-dependent signaling pathways.
Begum N; Duddy N; Sandu O; Reinzie J; Ragolia L
Mol Endocrinol; 2000 Sep; 14(9):1365-76. PubMed ID: 10976915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
